Bharat Biotech says typhoid vaccine shown to be safe, effective in human trialsPost published:October 2, 2017Post category:Industry NewsClinical studies showed 87% effectiveness for Typbar-TCV typhoid vaccine, says Bharat Biotech Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostMeet the Man Who Designed Your iPhone (It Wasn’t All Steve Jobs) Next PostD-Mart’s rising brand value shows that hyperlocal pays You Might Also Like Natcore Works to Develop Method for Low-Cost, High-Efficiency Solar Cells March 23, 2018 Balluff introduces BOS 21M ADCAP photoelectric sensor August 8, 2018 Very close to finalizing a ‘very promising alliance’: Rajiv Bajaj July 21, 2017